GSR
protein-codingglutathione-disulfide reductase
Gene summary
This gene encodes a member of the class-I pyridine nucleotide-disulfide oxidoreductase family. This enzyme is a homodimeric flavoprotein. It is a central enzyme of cellular antioxidant defense, and reduces oxidized glutathione disulfide (GSSG) to the sulfhydryl form GSH, which is an important cellular antioxidant. Rare mutations in this gene result in hereditary glutathione reductase deficiency. Multiple alternatively spliced transcript variants encoding different isoforms have been found. [provided by RefSeq, Aug 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~49.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0019531
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0019531
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0019531
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0019531
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Hematologic
Intervention: Hematologic
Rationale: Individuals are susceptible to hemolytic anemia, and awareness may allow early management as well as avoidance of triggers of hemolysis (eg, fava beans)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GSR variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000637.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 29 | 2 | 33 | ||
| missense | 1 | 1 | 121 | 13 | 2 | 138 |
| nonsense | 1 | 2 | 1 | 4 | ||
| start loss | 0 | |||||
| frameshift | 3 | 1 | 4 | |||
| splice donor/acceptor (+/-2bp) | 2 | 1 | 3 | |||
| Total | 4 | 6 | 126 | 42 | 4 | 182 |
Highest pathogenic variant AF is 0.00009516082
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000628.2 | 13 | MANE Select | |
| Ensembl | ENSP00000221130.5 | 13 | MANE Select | |
| RefSeq | NP_001182031.1 | 12 | Standard | |
| RefSeq | NP_001182032.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Thyroid hormone synthesis - Homo sapiens (human)
- Glutathione metabolism - Homo sapiens (human)
- Oxidative Stress Pathway (Erythrocyte)
- Pathway_PA165980337
- Oxidative Stress Pathway (Erythrocyte)
Biological Process
- glutathione metabolic process
- nucleobase-containing small molecule interconversion
- electron transport chain
- cellular response to oxidative stress
- cell redox homeostasis
Molecular Function
- glutathione-disulfide reductase activity
- electron transfer activity
- flavin adenine dinucleotide binding
- NADP binding
Cellular Component
- mitochondrion
- mitochondrial matrix
- cytosol
- external side of plasma membrane
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000221130
- Coding exons
- 13
- Length
- 49861
- Individuals with no LoFs
- 125713
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 35
- Defined
- 125748
- p
- 0.000139
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.512 | 247 | 271 | 0.912 | 0.0000154 | 3360 |
| Missense (PolyPhen) | 115 | 127.17 | 0.90428 | 1477 | ||
| Synonymous | 0.585 | 95 | 103 | 0.927 | 0.00000640 | 1047 |
| Loss of Function | 1.89 | 13 | 22.7 | 0.572 | 0.00000114 | 290 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00016 | 0.00016 | rare |
| South Asian | 0.00029 | 0.00029 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Maintains high levels of reduced glutathione in the cytosol.;
Intolerance Scores
- LoFtool
- 0.468
- RVIS EVS
- -0.36
- RVIS percentile EVS
- 29.31
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.909
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |